Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Environmental Geochemistry and Health|June 10, 2023
The situation of chlorpyrifos in Mexico: a case study in environmental samples and aquatic organismsMiguel Alfonso Ruiz-Arias, Irma Martha Medina-Díaz, Yael Yvette Bernal-Hernández, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|January 4, 2023
A postmortem study of patients vaccinated for SARS-CoV-2 in ColombiaJuan José Chaves, Juan Carlos Bonilla, Viviana Chaves-Cabezas, et al.
International Journal of Antimicrobial Agents|April 4, 2024
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trialCarmen Hidalgo-Tenorio, Sergio Sequera, María Jesus Vivancos, et al.
Plos One|January 18, 2013
Deep sequencing of RNA from ancient maize kernelsSarah L Fordyce, Maria C Ávila-Arcos, Morten Rasmussen, et al.
Plos One|January 20, 2026
Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
Plos One|September 22, 2025
Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
Infectious Diseases and Therapy|April 11, 2022
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish CohortRamón Teira, Helena Diaz-Cuervo, Filipa Aragão, et al.
NPJ Precision Oncology|January 7, 2026
Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AMLNeus Torres-Hernández, Elvira Mora, Cristian García-Ruiz, et al.
Dermatologic Therapy|June 22, 2022
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice settingPablo Chicharro, Mar Llamas-Velasco, Susana Armesto, et al.
Dermatology and Therapy|September 25, 2021
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in SpainEsteban Daudén, Glauber Pacelli Gomes de Lima, Susana Armesto, et al.
Pageof 17